Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases.
Li L, Huang Z, Chen Y, Ma H, Chen X, Yan H, Qin H, Zhang Y, Zhang X, Jiang W, Wang Z, Zhang L, Zeng F, Zhou Z, Pu X, Yang N, Zeng L, Zhang Y.
Li L, et al. Among authors: qin h.
Heliyon. 2024 Dec 7;10(24):e40703. doi: 10.1016/j.heliyon.2024.e40703. eCollection 2024 Dec 30.
Heliyon. 2024.
PMID: 39759323
Free PMC article.